5XJ-33183-96503
2 vaccinations
0 coded responses
23 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 194 / PA
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-16
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-18
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-22
- 2021-04-27
- 2021-06-15
- 2021-09-15
-
2021-10-27
Dose 2 — ModernaCo-administered: yes
- 2021-11-01
- 2021-11-02
- 2021-11-11
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-10
- 2022-01-26
- 2022-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-27 | Moderna | Yes |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.